Evaluation of the novel protein kinase C inhibitor sotrastaurin as immunosuppressive therapy after renal transplantation

Author： Matz Mareen   Naik Marcel   Mashreghi Mir-Farzin   Glander Petra   Neumayer Hans-H   Budde Klemens  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.7, Iss.1, 2011-01, pp. : 103-113

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protein Kinase C-theta Inhibitors: A Novel Therapy for Inflammatory Disorders

By  

Current Pharmaceutical Design, Vol. 18, Iss. 30, 2012-10 ,pp. : 4725-4746

Bentham Science Publishers

Access to resources Recommend Favorite

The Kinase Inhibitor Imatinib - An Immunosuppressive Drug?

By  

Current Cancer Drug Targets, Vol. 7, Iss. 3, 2007-05 ,pp. : 251-258

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Protein Kinase C-alpha (PKC-) in Cancer and its Modulation by the Novel PKC--Specific Inhibitor Aprinocarsen

By  

Current Pharmaceutical Design, Vol. 10, Iss. 16, 2004-06 ,pp. : 1923-1936

Bentham Science Publishers

Access to resources Recommend Favorite

THE RESPONSIVENESS OF THE ENDOGENOUS INHIBITOR OF cAMP-DEPENDENT PROTEIN KINASE TO ISOPROTERENOL AFTER PROLONGED TREATMENT WITH NIFEDIPINE

By Zalewska-Kaszubska J.   Marczak G.   Wejman I.   Wiktorowska A.  

Pharmacological Research, Vol. 37, Iss. 2, 1998-02 ,pp. : 151-155

Academic Press

Access to resources Recommend Favorite

Individualizing Calcineurin Inhibitor Therapy in Renal Transplantation - Current Limitations and Perspectives

By  

Current Pharmaceutical Design, Vol. 16, Iss. 2, 2010-01 ,pp. : 176-186

Bentham Science Publishers

Access to resources Recommend Favorite